[New symptomatic therapeutics].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D012110:Reserpine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D012110:Reserpine; D006145:Guanethidine
Les nouvelles thèrapeutiques symptomatiques.